Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.19.3.a.u2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 50,412 $ 68,379
Marketable securities - available-for-sale debt securities 39,130 136,755
Accounts receivable, net of allowance for doubtful accounts of $0 and $0   192
Other current assets and prepaid expenses (including current portion of clinical materials) 30,947 25,769
Total current assets 120,489 231,095
Restricted cash 4,496 4,097
Clinical materials 2,503 3,953
Operating lease right-of-use assets, net of accumulated amortization 20,789  
Property, plant and equipment, net of accumulated depreciation 31,068 36,118
Intangibles, net of accumulated amortization 2,198 1,473
Total assets 181,543 276,736
Current liabilities    
Accounts payable 6,357 4,083
Operating lease liabilities, current 2,493  
Accrued expenses and other accrued liabilities 23,363 20,354
Deferred revenue 2,128  
Total current liabilities 34,341 24,437
Operating lease liabilities, non-current 22,966  
Other liabilities, non-current 598 5,414
Total liabilities 57,905 29,851
Stockholders' equity    
Common stock - Ordinary shares par value 0.001, 785,857,300 authorized and 631,003,568 issued and outstanding (2018: 701,103,126 authorized and 627,454,270 issued and outstanding) 943 939
Additional paid in capital 585,623 574,208
Accumulated other comprehensive loss (7,264) (9,763)
Accumulated deficit (455,664) (318,499)
Total stockholders' equity 123,638 246,885
Total liabilities and stockholders' equity $ 181,543 $ 276,736